English Polski

Wyszuk. zaawans.

Tom 19 (2024): Continuous Publishing
Artykuł przeglądowy
Opublikowany online: 2024-10-28

dostęp otwarty

Pokaż PDF Pobierz plik PDF
Wyświetlenia strony 93
Wyświetlenia/pobrania artykułu 98
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Stanowisko Sekcji Dietetyki Medycznej POLSPEN dotyczące stosowania postu przerywanego w profilaktyce i leczeniu zaburzeń metabolicznych

Jolanta Dardzińska1, Sylwia Małgorzewicz1, Dariusz Włodarek2, Dorota Szostak-Węgierek3
DOI: 10.5603/pżk.101352
Postępy Żywienia Klinicznego 2024;19:123-132.

Streszczenie

Problem otyłości stale narasta. Wobec braku dostępnych i skutecznych rozwiązań, wielu pacjentów zwraca się ku niestandardowym formom terapii nadmiaru masy ciała. W ostatniej dekadzie znacznie wzrosło zainteresowanie stosowaniem tzw. postów przerywanych (IF, intermittent fasting) jako alternatywy dla ciągłej restrykcji kalorycznej. W pracy dokonano przeglądu piśmiennictwa dotyczącego skuteczności stosowania IF w leczeniu otyłości i towarzyszących jej zaburzeń metabolicznych. Dotychczasowe badania wykazały, że posty przerywane mogą być alternatywą dla klasycznej diety redukcyjnej, jednak nie ma wystarczających dowodów, że jego stosowanie wiąże się z większymi korzyściami zdrowotnymi. Przy podejmowaniu decyzji o stosowaniu tych reżimów dietetycznych należy wziąć pod uwagę ryzyko ewentualnych związanych z nimi zagrożeń.

Słowa kluczowe: post przerywanyotyłośćcukrzyca typu 2dyslipidemianadciśnienie tętniczestan zapalnyprzeciwwskazania

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. WHO EUROPEAN REGIONAL OBESITY REPORT 2022. https://www.who.int/europe/publications/i/item/9789289057738.
  2. Global Burden of Disease. Obesity. https://www.healthdata.org/search?search_api_fulltext=obesity.
  3. de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med. 2019; 381(26): 2541–2551.
    CrossRefPubMed
  4. Dorling JL, Martin CK, Redman LM. Calorie restriction for enhanced longevity: The role of novel dietary strategies in the present obesogenic environment. Ageing Res Rev. 2020; 64: 101038.
    CrossRefPubMed
  5. Redman LM, Ravussin E. Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal. 2011; 14(2): 275–287.
    CrossRefPubMed
  6. Attinà A, Leggeri C, Paroni R, et al. Fasting: How to Guide. Nutrients. 2021; 13(5).
    CrossRefPubMed
  7. Dong TA, Sandesara PB, Dhindsa DS, et al. Intermittent Fasting: A Heart Healthy Dietary Pattern? Am J Med. 2020; 133(8): 901–907.
    CrossRefPubMed
  8. Swindell WR. Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan. Ageing Res Rev. 2012; 11(2): 254–270.
    CrossRefPubMed
  9. Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science. 2010; 328(5976): 321–326.
    CrossRefPubMed
  10. Patterson RE, Laughlin GA, LaCroix AZ, et al. Intermittent Fasting and Human Metabolic Health. J Acad Nutr Diet. 2015; 115(8): 1203–1212.
    CrossRefPubMed
  11. Dong TA, Sandesara PB, Dhindsa DS, et al. Intermittent Fasting: A Heart Healthy Dietary Pattern? Am J Med. 2020; 133(8): 901–907.
    CrossRefPubMed
  12. de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med. 2019; 381(26): 2541–2551.
    CrossRefPubMed
  13. Walford RL, Mock D, Verdery R, et al. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci. 2002; 57(6): B211–B224.
    CrossRefPubMed
  14. Ravussin E, Redman LM, Rochon J, et al. CALERIE Study Group. A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity. J Gerontol A Biol Sci Med Sci. 2015; 70(9): 1097–1104.
    CrossRefPubMed
  15. Dorling JL, van Vliet S, Huffman KM, et al. CALERIE Study Group. Effects of caloric restriction on human physiological, psychological, and behavioral outcomes: highlights from CALERIE phase 2. Nutr Rev. 2021; 79(1): 98–113.
    CrossRefPubMed
  16. Halberg N, Henriksen M, Söderhamn N, et al. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol (1985). 2005; 99(6): 2128–2136.
    CrossRefPubMed
  17. Gjedsted J, Gormsen LC, Nielsen S, et al. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue. Acta Physiol (Oxf). 2007; 191(3): 205–216.
    CrossRefPubMed
  18. Donnelly LS, Shaw RL, Pegington M, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011; 35(5): 714–727.
    CrossRefPubMed
  19. Klempel MC, Kroeger CM, Bhutani S, et al. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012; 11: 98.
    CrossRefPubMed
  20. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism. 2013; 62(1): 137–143.
    CrossRefPubMed
  21. Patterson RE, Sears DD. Metabolic Effects of Intermittent Fasting. Annu Rev Nutr . 2017; 21(37): 371–393.
    CrossRefPubMed
  22. Varady KA, Cienfuegos S, Ezpeleta M, et al. Clinical application of intermittent fasting for weight loss: progress and future directions. Nat Rev Endocrinol. 2022; 18(5): 309–321.
    CrossRefPubMed
  23. Carlson O, Martin B, Stote KS, et al. Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women. Metabolism. 2007; 56(12): 1729–1734.
    CrossRefPubMed
  24. Stote KS, Baer DJ, Spears K, et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr. 2007; 85(4): 981–988.
    CrossRefPubMed
  25. Tinsley GM, Forsse JS, Butler NK, et al. Time-restricted feeding in young men performing resistance training: A randomized controlled trial. Eur J Sport Sci. 2017; 17(2): 200–207.
    CrossRefPubMed
  26. Patterson RE, Sears DD. Metabolic Effects of Intermittent Fasting. Annu Rev Nutr. 2017; 21(37): 371–393.
    CrossRefPubMed
  27. Longo VD, Panda S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab. 2016; 23(6): 1048–1059.
    CrossRefPubMed
  28. Paoli A, Tinsley G, Bianco A, et al. The Influence of Meal Frequency and Timing on Health in Humans: The Role of Fasting. Nutrients. 2019; 11(4).
    CrossRefPubMed
  29. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. 2012; 35: 445–462.
    CrossRefPubMed
  30. Unger J, McNeill TH, Moxley RT, et al. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience. 1989; 31(1): 143–157.
    CrossRefPubMed
  31. Zigman JM, Jones JE, Lee CE, et al. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol. 2006; 494(3): 528–548.
    CrossRefPubMed
  32. Hâkansson ML, Brown H, Ghilardi N, et al. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998; 18(1): 559–572.
    CrossRefPubMed
  33. Gamble KL, Berry R, Frank SJ, et al. Circadian clock control of endocrine factors. Nat Rev Endocrinol. 2014; 10(8): 466–475.
    CrossRefPubMed
  34. Stenvers DJ, Scheer FA, Schrauwen P, et al. Circadian clocks and insulin resistance. Nat Rev Endocrinol. 2019; 15(2): 75–89.
    CrossRefPubMed
  35. Gibbs M, Harrington D, Starkey S, et al. Diurnal postprandial responses to low and high glycaemic index mixed meals. Clin Nutr. 2014; 33(5): 889–894.
    CrossRefPubMed
  36. Morgan L, Hampton S, Gibbs M, et al. Circadian aspects of postprandial metabolism. Chronobiol Int. 2003; 20(5): 795–808.
    CrossRefPubMed
  37. Saad A, Dalla Man C, Nandy DK, et al. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012; 61(11): 2691–2700.
    CrossRefPubMed
  38. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988; 81(2): 442–448.
    CrossRefPubMed
  39. Romon M, Edme JL, Boulenguez C, et al. Circadian variation of diet-induced thermogenesis. Am J Clin Nutr. 1993; 57(4): 476–480.
    CrossRefPubMed
  40. Bo S, Fadda M, Castiglione A, et al. Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study. Int J Obes (Lond). 2015; 39(12): 1689–1695.
    CrossRefPubMed
  41. Fukuda Y, Morita T. Effects of the light-dark cycle on diurnal rhythms of diet-induced thermogenesis in humans. Chronobiol Int. 2017; 34(10): 1465–1472.
    CrossRefPubMed
  42. Scheer FA, Hilton MF, Mantzoros CS, et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009; 106(11): 4453–4458.
    CrossRefPubMed
  43. Challet E. Circadian clocks, food intake, and metabolism. Prog Mol Biol Transl Sci. 2013; 119: 105–135.
    CrossRefPubMed
  44. Harvie MN, Howell T. Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence. Adv Nutr. 2016; 7(4): 690–705.
    CrossRefPubMed
  45. Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med. 2012; 18(1): 1249–1260.
    CrossRefPubMed
  46. Stevens RG, Blask DE, Brainard GC, et al. Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect. 2007; 115(9): 1357–1362.
    CrossRefPubMed
  47. Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 2001; 12(3): 279–287.
    CrossRefPubMed
  48. Straif K, Baan R, Grosse Y, et al. WHO International Agency For Research on Cancer Monograph Working Group. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8(12): 1065–1066.
    CrossRefPubMed
  49. Arble DM, Bass J, Behn CD, et al. Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions. Sleep. 2015; 38(12): 1849–1860.
    CrossRefPubMed
  50. Roky R, Houti I, Moussamih S, et al. Physiological and chronobiological changes during Ramadan intermittent fasting. Ann Nutr Metab. 2004; 48(4): 296–303.
    CrossRefPubMed
  51. Boukhris O, Hill DW, Ammar A, et al. Longer Nap Duration During Ramadan Observance Positively Impacts 5-m Shuttle Run Test Performance Performed in the Afternoon. Front Physiol. 2022; 13: 811435.
    CrossRefPubMed
  52. Chowdhury EA, Richardson JD, Holman GD, et al. The causal role of breakfast in energy balance and health: a randomized controlled trial in obese adults. Am J Clin Nutr. 2016; 103(3): 747–756.
    CrossRefPubMed
  53. Chowdhury EA, Richardson JD, Tsintzas K, et al. Effect of extended morning fasting upon ad libitum lunch intake and associated metabolic and hormonal responses in obese adults. Int J Obes (Lond). 2016; 40(2): 305–311.
    CrossRefPubMed
  54. Liśkiewicz A, Jędrzejewska-Szypułka H, Lewin-Kowalik J. Characteristics of ketogenic diet and its therapeutic properties in central nervous system disorders. Ann. Acad. Med. Siles. 2012; 66(6): 66–76.
  55. Steinhauser ML, Olenchock BA, O'Keefe J, et al. The circulating metabolome of human starvation. JCI Insight. 2018; 3(16).
    CrossRefPubMed
  56. Sanvictores T, Casale J, Huecker MR. Physiology, Fasting. StatPearls Publishing 2023: https://www.ncbi.nlm.nih.gov/books/NBK534877/.
  57. Paoli A, Bianco A, Damiani E, et al. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int. 2014; 2014: 474296.
    CrossRefPubMed
  58. Włodarek D, Włodarek D, Włodarek D. Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease). Nutrients. 2019; 11(1): 385–391.
    CrossRefPubMed
  59. Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzyme Regul. 1966; 4: 339–354.
    CrossRefPubMed
  60. McCue MD. Starvation physiology: reviewing the different strategies animals use to survive a common challenge. Comp Biochem Physiol A Mol Integr Physiol. 2010; 156(1): 1–18.
    CrossRefPubMed
  61. Harris L, Hamilton S, Azevedo LB, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep. 2018; 16(2): 507–547.
    CrossRefPubMed
  62. Allaf M, Elghazaly H, Mohamed OG, et al. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021; 1(1): CD013496.
    CrossRefPubMed
  63. Welton S, Minty R, O'Driscoll T, et al. Intermittent fasting and weight loss: Systematic review. Can Fam Physician. 2020; 66(2): 117–125.
    PubMed
  64. Morales-Suarez-Varela M, Collado Sánchez E, Peraita-Costa I, et al. Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials. Nutrients. 2021; 13(9).
    CrossRefPubMed
  65. He S, Wang J, Zhang J, et al. Intermittent Versus Continuous Energy Restriction for Weight Loss and Metabolic Improvement: A Meta-Analysis and Systematic Review. Obesity (Silver Spring). 2021; 29(1): 108–115.
    CrossRefPubMed
  66. Varady KA, Cienfuegos S, Ezpeleta M, et al. Clinical application of intermittent fasting for weight loss: progress and future directions. Nat Rev Endocrinol. 2022; 18(5): 309–321.
    CrossRefPubMed
  67. Wang J, Wang F, Chen H, et al. Comparison of the Effects of Intermittent Energy Restriction and Continuous Energy Restriction among Adults with Overweight or Obesity: An Overview of Systematic Reviews and Meta-Analyses. Nutrients. 2022; 14(11).
    CrossRefPubMed
  68. Ezzati A, Rosenkranz SK, Phelan J, et al. The Effects of Isocaloric Intermittent Fasting vs Daily Caloric Restriction on Weight Loss and Metabolic Risk Factors for Noncommunicable Chronic Diseases: A Systematic Review of Randomized Controlled or Comparative Trials. J Acad Nutr Diet. 2023; 123(2): 318–329.e1.
    CrossRefPubMed
  69. Wei X, Lin B, Huang Y, et al. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. N Engl J Med. 2022; 386(16): 1495–1504.
    CrossRefPubMed
  70. Headland ML, Clifton PM, Keogh JB. Effect of intermittent compared to continuous energy restriction on weight loss and weight maintenance after 12 months in healthy overweight or obese adults. Int J Obes (Lond). 2019; 43(10): 2028–2036.
    CrossRefPubMed
  71. He S, Wang J, Zhang J, et al. Intermittent Versus Continuous Energy Restriction for Weight Loss and Metabolic Improvement: A Meta-Analysis and Systematic Review. Obesity (Silver Spring). 2021; 29(1): 108–115.
    CrossRefPubMed
  72. Coutinho SR, Halset EH, Gåsbakk S, et al. Compensatory mechanisms activated with intermittent energy restriction: A randomized control trial. Clin Nutr. 2018; 37(3): 815–823.
    CrossRefPubMed
  73. Hall KD, Guo J. Obesity Energetics: Body Weight Regulation and the Effects of Diet Composition. Gastroenterology. 2017; 152(7): 1718–1727.e3.
    CrossRefPubMed
  74. Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Society. Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. J Am Pharm Assoc (2003). 2013 [Epub ahead of print]; 129(25 Suppl 2): e3–S138.
    CrossRefPubMed
  75. Silverii GA, Cresci B, Benvenuti F, et al. Effectiveness of intermittent fasting for weight loss in individuals with obesity: A meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2023; 33(8): 1481–1489.
    CrossRefPubMed
  76. Schroor MM, Joris PJ, Plat J, et al. Effects of Intermittent Energy Restriction Compared with Those of Continuous Energy Restriction on Body Composition and Cardiometabolic Risk Markers - A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults. Adv Nutr. 2024; 15(1): 100130.
    CrossRefPubMed
  77. Ma Y, Sun L, Mu Z. Network meta-analysis of three different forms of intermittent energy restrictions for overweight or obese adults. Int J Obes (Lond). 2024; 48(1): 55–64.
    CrossRefPubMed
  78. Harvie M, Wright C, Pegington M, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013; 110(8): 1534–1547.
    CrossRefPubMed
  79. Sutton EF, Beyl R, Early KS, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018; 27(6): 1212–1221.e3.
    CrossRefPubMed
  80. Anton SD, Moehl K, Donahoo WT, et al. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting. Obesity (Silver Spring). 2018; 26(2): 254–268.
    CrossRefPubMed
  81. Vasim I, Majeed CN, DeBoer MD. Intermittent Fasting and Metabolic Health. Nutrients. 2022; 14(3).
    CrossRefPubMed
  82. Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med. 2020; 180(11): 1491–1499.
    CrossRefPubMed
  83. Furmli S, Elmasry R, Ramos M, et al. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Reports. 2018; 2018: bcr-2017-221854.
    CrossRef
  84. Alghamdi AS, Alghamdi KA, Jenkins RO, et al. Impact of Ramadan on Physical Activity and Sleeping Patterns in Individuals with Type 2 Diabetes: The First Study Using Fitbit Device. Diabetes Ther. 2020; 11(6): 1331–1346.
    CrossRefPubMed
  85. Obermayer A, Tripolt NJ, Pferschy PN, et al. Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial. Diabetes Care. 2023; 46(2): 463–468.
    CrossRefPubMed
  86. Yuan X, Wang J, Yang S, et al. Effect of Intermittent Fasting Diet on Glucose and Lipid Metabolism and Insulin Resistance in Patients with Impaired Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis. Int J Endocrinol. 2022; 2022: 6999907.
    CrossRefPubMed
  87. Pureza IR, Macena Md, da Silva Junior AE, et al. Effect of early time-restricted feeding on the metabolic profile of adults with excess weight: A systematic review with meta-analysis. Clin Nutr. 2021; 40(4): 1788–1799.
    CrossRefPubMed
  88. Crupi AN, Haase J, Brandhorst S, et al. Periodic and Intermittent Fasting in Diabetes and Cardiovascular Disease. Curr Diab Rep. 2020; 20(12): 83.
    CrossRefPubMed
  89. Erdem Y, Özkan G, Ulusoy Ş, et al. Turkish Society of Hypertension and Renal Diseases. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension. J Am Soc Hypertens. 2018; 12(1): 42–49.
    CrossRefPubMed
  90. Wilhelmi de Toledo F, Grundler F, Bergouignan A, et al. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019; 14(1): e0209353.
    CrossRefPubMed
  91. Eshghinia S, Mohammadzadeh F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord. 2013; 12(1): 4.
    CrossRefPubMed
  92. Teng NI, Shahar S, Rajab NF, et al. Improvement of metabolic parameters in healthy older adult men following a fasting calorie restriction intervention. Aging Male. 2013; 16(4): 177–183.
    CrossRefPubMed
  93. Bhutani S, Klempel MC, Kroeger CM, et al. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring). 2013; 21(7): 1370–1379.
    CrossRefPubMed
  94. Malinowski B, Zalewska K, Węsierska A, et al. Intermittent Fasting in Cardiovascular Disorders-An Overview. Nutrients. 2019; 11(3).
    CrossRefPubMed
  95. Liu Bo, Hutchison AT, Thompson CH, et al. Markers of adipose tissue inflammation are transiently elevated during intermittent fasting in women who are overweight or obese. Obes Res Clin Pract. 2019; 13(4): 408–415.
    CrossRefPubMed
  96. Castela I, Rodrigues C, Ismael S, et al. Intermittent energy restriction ameliorates adipose tissue-associated inflammation in adults with obesity: A randomised controlled trial. Clin Nutr. 2022; 41(8): 1660–1666.
    CrossRefPubMed
  97. Wang X, Yang Q, Liao Q, et al. Effects of intermittent fasting diets on plasma concentrations of inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials. Nutrition. 2020; 79-80: 110974.
    CrossRefPubMed
  98. Lavallee CM, Bruno A, Ma C, et al. The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review. Nutrients. 2022; 14(21).
    CrossRefPubMed
  99. Choi JH, Cho YJ, Kim HJ, et al. Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO), Committee of Clinical Practice Guidelines and Committee of Food and Nutrition, Korean Diabetes Association (KDA), Policy Committee of Korean Society of Hypertension (KSH), Policy Development Committee of National Academy of Medicine of Korea (NAMOK). Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension. Diabetes Metab J. 2022; 46(3): 355–376.
    CrossRefPubMed

Informacje o plikach cookie

Niezbędne pliki cookie

Zawsze aktywne

Te pliki cookie są niezbędne do prawidłowego wyświetlania i działania strony internetowej. Zablokowanie ich może spowodować nieprawidłowe działanie strony.

Analityczne pliki cookie

W ramach naszej strony internetowej korzystamy z narzędzi analitycznych, takich jak Google Analytics, które umożliwiają nam weryfikację ruchu na stronie internetowej. Narzędzia te mogą wymagać użycia plików cookie.

Społecznościowe pliki cookie

Są to pliki cookie powiązane z portalami społecznościowymi, z których korzystamy. Zaakceptowanie ich pozwoli na powiązanie Twojej wizyty na stronie z naszymi profilami w mediach społecznościowych.

Marketingowe pliki cookie

Są to pliki cookie odpowiedzialne za prowadzenie działań reklamowych i marketingowych - zgoda na ich wykorzystanie pozwoli nam kierować do Ciebie reklamy, bazujące na podstawie Twoich wcześniejszych aktywności w ramach naszej stronie internetowej.

Copyright © 2023-2024 Via Medica Regulamin Polityka cookies Polityka prywatności Nota prawna